Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples